Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Developmental toxicity / teratogenicity

Currently viewing:

Administrative data

Endpoint:
developmental toxicity
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
weight of evidence
Study period:
No data
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
other: Abstract only available; suitable only as part of a WoE assessment

Data source

Reference
Reference Type:
publication
Title:
A teratology screening study in rats with n-hexanol
Author:
Rodwell DE, Mercieca MD, Rusch CM & Tasker EJ
Year:
1988
Bibliographic source:
Toxicologist 8(1):213 (1988)

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 414 (Prenatal Developmental Toxicity Study)
GLP compliance:
not specified
Limit test:
no

Test material

Constituent 1
Reference substance name:
n-Hexanol
IUPAC Name:
n-Hexanol
Test material form:
not specified
Details on test material:
- Name of test material (as cited in study report): n-hexanol

Test animals

Species:
rat
Strain:
other: COBS CD
Details on test animals or test system and environmental conditions:
25 mated female COBS CD rats per group..

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
corn oil
Details on exposure:
N-hexanol was mixed with corn oil and administered by oral gavage at doses of 200 or 1000 mg/kg bw/day. Each group consisted of 25 mated female COBS CD rats. Ten consecutive daily doses were administered over gestation days 6-15, in a dose volume of 5 ml/kg bw.
Analytical verification of doses or concentrations:
not specified
Details on analytical verification of doses or concentrations:
No information
Details on mating procedure:
No data
Duration of treatment / exposure:
ten days GD 6-15
Frequency of treatment:
daily
Duration of test:
dams terminated on gestation day 20
Doses / concentrations
Remarks:
Doses / Concentrations:
200 or 1000 mg/kg bw/day
Basis:
nominal conc.
No. of animals per sex per dose:
25 mated females per group
Control animals:
no
Details on study design:
No further details available

Examinations

Maternal examinations:
Throughout gestation the rats were observed for appearance and behaviour, and bodyweights were recorded. On gestation day 20 intrauterine survival was evaluated following Caesarean section and foetal development indices – bodyweight, external, skeletal and visceral morphology – were assessed.
Ovaries and uterine content:
The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: No data
- Number of corpora lutea: No data
- Number of implantations: Yes
- Number of early resorptions: Yes
- Number of late resorptions: Yes
- Other: intrauterine survival and foetal development indices
Fetal examinations:
On gestation day 20 intrauterine survival was evaluated following Caesarean section and foetal development indices – bodyweight, external, skeletal and visceral morphology – were assessed.
Statistics:
No data
Indices:
No information presented on how foetal development indices were determined
Historical control data:
No data

Results and discussion

Results: maternal animals

Maternal developmental toxicity

Details on maternal toxic effects:
Maternal toxic effects:yes. Remark: 1000 mg/kg bw/day

Details on maternal toxic effects:
Maternal toxicity was only evident at 1000 mg/kg bw/day – indicated by clinical signs and decreased maternal bodyweights during the treatment period.

Effect levels (maternal animals)

Dose descriptor:
NOAEL
Effect level:
200 mg/kg bw/day
Based on:
test mat.
Basis for effect level:
other: maternal toxicity

Results (fetuses)

Details on embryotoxic / teratogenic effects:
Embryotoxic / teratogenic effects:no effects. Remark: No embryotoxicity or teratologic effects were observed at either dose level.

Details on embryotoxic / teratogenic effects:
No embryotoxicity or teratologic effects were observed at either dose level.

Effect levels (fetuses)

Dose descriptor:
NOAEL
Effect level:
200 mg/kg bw/day
Based on:
test mat.
Basis for effect level:
other: developmental toxicity

Fetal abnormalities

Abnormalities:
not specified

Overall developmental toxicity

Developmental effects observed:
not specified

Any other information on results incl. tables

Mean foetal bodyweight was slightly decreased at 1000 mg/kg bw/day, but weights were within the laboratory historical range. An increase in the number of litters with the foetal variant ‘malaligned sternebrae’ occurred at the low dose level, 200 mg/kg bw/day. The incidence of this variation in the high dose group was similar to incidence in the controls.

Applicant's summary and conclusion

Conclusions:
Maternal toxicity and developmental toxicity were evident at the highest dose level of 1000 mg/kg bw/d; there is no evidence for specific developmental toxicity.
Executive summary:

The potential maternal, embryotoxic and teratologic effects of N-hexanol were evaluated. N-hexanol was mixed with corn oil and administered by oral gavage at doses of 200 or 1000 mg/kg bw/day. Each group consisted of 25 mated female COBS CD rats. Ten consecutive daily doses were administered over gestation days 6-15, in a dose volume of 5 ml/kg bw. Throughout gestation the rats were observed for appearance and behaviour, and bodyweights were recorded. On gestation day 20 intrauterine survival was evaluated following Caesarean section and foetal development indices – bodyweight, external, skeletal and visceral morphology – were assessed. No embryotoxicity or teratologic effects were observed at either dose level. Maternal toxicity was only evident at 1000 mg/kg bw/day – indicated by clinical signs and decreased maternal bodyweights during the treatment period. Mean foetal bodyweight was slightly decreased at 1000 mg/kg bw/day, but weights were within the laboratory historical range.  An increase in the number of litters with the foetal variant ‘malaligned sternebrae’ occurred at the low dose level, 200 mg/kg bw/day. The incidence of this variation in the high dose group was similar to incidence in the controls. The 200 mg/kg bw/day dose level was considered a no-effect level. Maternal toxicity and developmental toxicity were evident at the highest dose level of 1000 mg/kg bw/d; there is no evidence for specific developmental toxicity.